Article
Common anti-platelet therapies modulate procoagulant phospholipids in arterial disease
2022-11-04
Abstract excerpt
Enzymatically oxygenated phospholipids (eoxPL) formed by lipoxygenases (LOX) and cyclooxygenase (COX) in platelets and leukocytes are pro-coagulant in multiple model systems. However, their generation in arterial thrombotic disease, and how their levels are modulated by common therapies is unknown. Here, eoxPL were first characterized in isolated platelets and leukocytes from an arterial vascular disease cohort, a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 88a0b973-decc-5513-b3e6-6a2089185ed7
- DOI
- 10.1101/2022.11.03.22280948
